Lü Mu-Han, Deng Jia-Qi, Cao Ya-Ling, Fang Dian-Chun, Zhang Yao, Yang Shi-Ming
Institute of Gastroenterology, Southwest Hospital, Third Military Medical University;
Exp Ther Med. 2012 Apr;3(4):728-734. doi: 10.3892/etm.2012.471. Epub 2012 Feb 3.
Activation of telomerase is involved in carcinogenesis in most types of cancers. However, the prognostic value of telomerase activity (TA) in patients with gastric carcinoma (GC) remains controversial. We conducted a meta-analysis to assess the relationship between TA and the clinical outcome of GC. A meta-analysis of 18 studies (886 patients) was performed to evaluate the association between TA and metastasis-related parameters in GC patients by searching databases, including PubMed, MEDLINE, EMBASE, Web of Science databases, Cochrane Library and the Chinese Biomedical Literature database (CBM) (last search updated in October 2011). We used the odds ratios (ORs) with 95% confidence intervals (CIs) to assess the strength of the association between TA and metastasis of GC. Our analysis results indicated that high telomerase activity expression tended to be associated with the presence of lymph node metastasis (866 patients) (OR=2.03, 95% CI 1.21-3.39, p=0.007), the depth of invasion (886 patients) (OR=1.87, 95% CI 1.30-2.70, p=0.0007), distant metastasis (407 patients) (OR=2.71, 95% CI 1.59-4.63, p=0.0002), tumor size (466 patients) (OR=2.14, 95% CI 1.31-3.50, p=0.002) and TNM stage (711 patients) (OR=2.39, 95% CI 1.30-4.41, p=0.005). However, high TA expression was not associated with the presence of histologic differentiation (791 patients) (OR=1.51, 95% CI 0.73-3.11, p=0.26). In conclusion, telomerase overexpression not only plays a key role in primary initiation, but also promotes invasion and metastatic progression of GC. These findings raise the possibility of using TA to screen for the prognosis of gastric cancer.
端粒酶激活参与了大多数类型癌症的致癌过程。然而,端粒酶活性(TA)在胃癌(GC)患者中的预后价值仍存在争议。我们进行了一项荟萃分析,以评估TA与GC临床结局之间的关系。通过检索包括PubMed、MEDLINE、EMBASE、Web of Science数据库、Cochrane图书馆和中国生物医学文献数据库(CBM)(最后一次检索更新于2011年10月)在内的数据库,对18项研究(886例患者)进行荟萃分析,以评估TA与GC患者转移相关参数之间的关联。我们使用比值比(OR)及95%置信区间(CI)来评估TA与GC转移之间关联的强度。我们的分析结果表明,端粒酶高活性表达往往与存在淋巴结转移(866例患者)(OR=2.03,95%CI 1.21 - 3.39,p=0.007)、浸润深度(886例患者)(OR=1.87,95%CI 1.30 - 2.70,p=0.0007)、远处转移(407例患者)(OR=2.71,95%CI 1.59 - 4.63,p=0.0002)、肿瘤大小(466例患者)(OR=2.14,95%CI 1.31 - 3.50,p=0.002)和TNM分期(711例患者)(OR=2.39,95%CI 1.30 - 4.41,p=0.005)相关。然而,TA高表达与组织学分化存在(791例患者)无关(OR=1.51,95%CI 0.73 - 3.11,p=0.26)。总之,端粒酶过表达不仅在肿瘤原发起始中起关键作用,还促进GC的侵袭和转移进展。这些发现增加了使用TA来筛查胃癌预后的可能性。